These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9551870)

  • 1. Break-through for calcium antagonists in the treatment of hypertension based on the Syst-Eur results.
    Hansson L; Hedner T; Jern S
    Blood Press; 1998 Jan; 7(1):3-4. PubMed ID: 9551870
    [No Abstract]   [Full Text] [Related]  

  • 2. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An overview of hypertension studies with calcium antagonists].
    Kjeldsen SE; Midtbø K; Os I; Westheim A
    Tidsskr Nor Laegeforen; 1999 May; 119(13):1878-82. PubMed ID: 10382332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The calcium channel antagonist controversy.
    Gavras I; Gavras H
    Am Fam Physician; 1998 Apr; 57(7):1484, 1492. PubMed ID: 9556636
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the Systolic Hypertension in Europe (Syst-Eur) trial.
    Birkenhäger WH; Staessen JA; Gasowski J; de Leeuw PW
    J Nephrol; 2000; 13(3):232-7. PubMed ID: 10928302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Back to basics: diuretics as first-line agents in the treatment of hypertension.
    Mandal VJ
    J Am Geriatr Soc; 2004 Jul; 52(7):1210-1. PubMed ID: 15209664
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of arterial hypertension for cardio-cerebral protection: role of calcium antagonists].
    De Gregorio G; De Gregorio C
    Clin Ter; 1988 Dec; 127(5):335-41. PubMed ID: 2976631
    [No Abstract]   [Full Text] [Related]  

  • 8. Antihypertensive treatment and CHD in the elderly.
    Fink KS; Ellsworth A
    Am Fam Physician; 1999 Sep; 60(4):1102, 1104, 1107. PubMed ID: 10507742
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of hypertension in the elderly].
    Hohage H; Gerhardt U; Suwelack BM
    Med Klin (Munich); 2003 Sep; 98(9):511-21. PubMed ID: 14551708
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term treatment with calcium antagonists: advantageous effects and risks].
    van Zwieten PA; Tijssen JG; Lie KI; de Leeuw PW
    Ned Tijdschr Geneeskd; 1995 Dec; 139(52):2715-21. PubMed ID: 8569884
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Are all antihypertensive agents equal? Cardiovascular events in hypertensive patients randomized to treatment with doxazosin or chlorthalidone. The ALLHAT study].
    Schillaci G; Verdecchia P
    Ital Heart J Suppl; 2000 Sep; 1(9):1215-7. PubMed ID: 11140297
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials.
    Cucherat M
    Eur Heart J; 2007 Dec; 28(24):3012-9. PubMed ID: 17981830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SYST-EUR Study--calcium channel blockers coming of age? European Trial on Isolated Systolic Hypertension in the Elderly.
    Potter JF
    J Hum Hypertens; 1997 Oct; 11(10):619-20. PubMed ID: 9400901
    [No Abstract]   [Full Text] [Related]  

  • 17. [Calcium antagonists in therapy of hypertension. Effective in preventing stroke?].
    Rafflenbeul W
    MMW Fortschr Med; 2001 Aug; 143(31-32):33-4. PubMed ID: 11556185
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preventing end-organ damage in hypertension. What is the significance of the VALUE Study for general practice?].
    Zidek W
    MMW Fortschr Med; 2004 Jul; 146(27-28):41. PubMed ID: 15526662
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcium channel blockers: the present and the future.
    Pieper JA
    Pharmacotherapy; 1997; 17(2):408-12. PubMed ID: 9085340
    [No Abstract]   [Full Text] [Related]  

  • 20. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Trial: focus on the diabetic patient.
    Berecek KH; Farag A; Bahtiyar G; Rothman J; McFarlane SI
    Curr Hypertens Rep; 2004 Jun; 6(3):212-4. PubMed ID: 15128474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.